Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy/dy mouse model by glatiramer acetate
Authors:
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Clinical Neurophysiology
- Vol. 130 (10) , 1988-1994
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Developmental Regulation of MicroRNA Expression in Schwann CellsMolecular and Cellular Biology, 2012
- Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple SclerosisPLOS ONE, 2011
- Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategiesSkeletal Muscle, 2011
- The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J miceNeuroscience Letters, 2010
- Noninvasive model of sciatic nerve conduction in healthy and septic mice: Reliability and normative dataMuscle & Nerve, 2009
- Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of Cisplatin-induced neuropathyBMC Neuroscience, 2009
- Peripheral myelin protein 22 is regulated post‐transcriptionally by miRNA‐29aGlia, 2009
- Both Laminin and Schwann Cell Dystroglycan Are Necessary for Proper Clustering of Sodium Channels at Nodes of RanvierJournal of Neuroscience, 2005
- Coordinate control of axon defasciculation and myelination by laminin-2 and -8Journal of Cell Biology, 2005
- Schwann cell myelination occurred without basal lamina formation in laminin α2 chain‐null mutant (dy3K/dy3K) miceGlia, 2001